HealthDealStreetAsiaabout 1 hour ago
UltraGreen.ai Posts 35% Revenue Growth
3 min read
Singapore-listed surgical imaging company UltraGreen.ai reported a 35% increase in nine-month revenue to $131.8 million. However, the firm lowered its FY2026 outlook below $175 to $185 million due to intensified US competition. CEO Ravinder Sajwan cited pricing pressure from new indocyanine green products from Zydus Lifesciences and Provepharm.
Level
Hype check
Tap to vote and see what everyone thinks.
